Behavior Modification Only Answer to Aids Epidemic

By Watkins, Robert | THE JOURNAL RECORD, June 27, 1990 | Go to article overview
Save to active project

Behavior Modification Only Answer to Aids Epidemic


Watkins, Robert, THE JOURNAL RECORD


The fear of AIDS - Acquired Immune Deficiency Syndrome - still haunts the land. And, last week, as the scientific experts gathered in San Francisco to exchange information, neither a cure nor a preventive vaccine was in sight.

So, what does an alarmed populace do about it?

Sensibly, the Oklahoma State Department of Health argues for a reduction in risk taking.

Since January, department spokesman Dick Gunn reports, 203 Oklahomans have tested positive for HIV infection, the viral precursor of the disease itself. It may lurk in the body for five or as many as 10 years before the affected individual becomes an AIDS victim, requiring very expensive and generally unproven medications.

Gunn said 14 new cases were reported to the department in May, bringing the year's total to 83, an increase of 21 over the same period last year. Oklahoma's total, since reporting began in January 1983, now stands at 617.

Among the more hopful revelations at the international AIDS conference in San Francisco was a Scandinavian claim that the drug isoprinosine appears to delay onset of the disease. American researchers, however, were skeptical.

The Scandinavians, led by Dr. Court Pederson of Copenhagen, say a random study of 856 patients revealed that those who received the drug were less likely to develop AIDS symptoms within 24 weeks. They were measured against patients who received a placebo - a dummy substance.

Three officials of the federal Food and Drug Administration, Drs. Sandra Dweder, Robert Schnur and Ellen C. Cooper, said the conclusions ought to be viewed with "considerable caution."

They noted that the study found no changes in other markers of AIDS virus infections. There were, for example, no increases in the number of immune system cells, or decreases in viral proteins often seen in the blood of infected people.

Several other American researchers said they agreed with the Food and Drug Administration's observations.

During the 24 weeks of the Scandinavian trials, two patients who took the active drug came down with AIDS.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
Loading One moment ...
Project items
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited article

Behavior Modification Only Answer to Aids Epidemic
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

While we understand printed pages are helpful to our users, this limitation is necessary to help protect our publishers' copyrighted material and prevent its unlawful distribution. We are sorry for any inconvenience.
Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.

Are you sure you want to delete this highlight?